OC.02.3 FOURTEEN-DAY, HIGH-DOSE ACID SUPPRESSION, NON-BISMUTH QUADRUPLE THERAPIES (“HYBRID” VS. “CONCOMITANT”) FOR HELICOBACTER PYLORI ERADICATION: A RANDOMISED TRIAL